BBIO
Price
$46.28
Change
+$0.62 (+1.36%)
Updated
Jul 25 closing price
Capitalization
8.79B
8 days until earnings call
DRTS
Price
$3.06
Change
+$0.04 (+1.32%)
Updated
Jul 25 closing price
Capitalization
259.55M
24 days until earnings call
Interact to see
Advertisement

BBIO vs DRTS

Header iconBBIO vs DRTS Comparison
Open Charts BBIO vs DRTSBanner chart's image
BridgeBio Pharma
Price$46.28
Change+$0.62 (+1.36%)
Volume$1.51M
Capitalization8.79B
Alpha Tau Medical
Price$3.06
Change+$0.04 (+1.32%)
Volume$25.67K
Capitalization259.55M
BBIO vs DRTS Comparison Chart in %
Loading...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BBIO vs. DRTS commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBIO is a Hold and DRTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (BBIO: $46.28 vs. DRTS: $3.06)
Brand notoriety: BBIO and DRTS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBIO: 55% vs. DRTS: 59%
Market capitalization -- BBIO: $8.79B vs. DRTS: $259.55M
BBIO [@Biotechnology] is valued at $8.79B. DRTS’s [@Biotechnology] market capitalization is $259.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBIO’s FA Score shows that 1 FA rating(s) are green whileDRTS’s FA Score has 0 green FA rating(s).

  • BBIO’s FA Score: 1 green, 4 red.
  • DRTS’s FA Score: 0 green, 5 red.
According to our system of comparison, BBIO is a better buy in the long-term than DRTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBIO’s TA Score shows that 3 TA indicator(s) are bullish while DRTS’s TA Score has 5 bullish TA indicator(s).

  • BBIO’s TA Score: 3 bullish, 5 bearish.
  • DRTS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, DRTS is a better buy in the short-term than BBIO.

Price Growth

BBIO (@Biotechnology) experienced а -0.49% price change this week, while DRTS (@Biotechnology) price change was +0.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

BBIO is expected to report earnings on Aug 05, 2025.

DRTS is expected to report earnings on Aug 21, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBIO($8.79B) has a higher market cap than DRTS($260M). BBIO YTD gains are higher at: 68.659 vs. DRTS (-1.290). DRTS has higher annual earnings (EBITDA): -32.33M vs. BBIO (-551.92M). BBIO has more cash in the bank: 541M vs. DRTS (51.6M). DRTS has less debt than BBIO: DRTS (12.3M) vs BBIO (1.86B). BBIO has higher revenues than DRTS: BBIO (127M) vs DRTS (0).
BBIODRTSBBIO / DRTS
Capitalization8.79B260M3,381%
EBITDA-551.92M-32.33M1,707%
Gain YTD68.659-1.290-5,321%
P/E RatioN/AN/A-
Revenue127M0-
Total Cash541M51.6M1,048%
Total Debt1.86B12.3M15,106%
FUNDAMENTALS RATINGS
BBIO: Fundamental Ratings
BBIO
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBIODRTS
RSI
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
69%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
57%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
60%
Advances
ODDS (%)
Bullish Trend 14 days ago
79%
Bullish Trend 3 days ago
65%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 7 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XSLV45.970.14
+0.31%
Invesco S&P SmallCap Low Volatility ETF
SLNZ47.260.02
+0.04%
TCW Senior Loan ETF
FLBL24.26-0.01
-0.04%
Franklin Senior Loan ETF
EVAV27.26-0.02
-0.06%
Direxion Dl Elctrc&Atnms vhcls Bull2XETF
BATT10.49-0.07
-0.66%
Amplify Lithium & Battery Tech ETF

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with ROIV. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
+1.36%
ROIV - BBIO
45%
Loosely correlated
N/A
XENE - BBIO
44%
Loosely correlated
-2.29%
CYTK - BBIO
41%
Loosely correlated
-0.35%
IONS - BBIO
41%
Loosely correlated
N/A
CGEN - BBIO
41%
Loosely correlated
-0.65%
More

DRTS and

Correlation & Price change

A.I.dvisor tells us that DRTS and ARDX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DRTS and ARDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRTS
1D Price
Change %
DRTS100%
+1.32%
ARDX - DRTS
28%
Poorly correlated
-1.61%
BBIO - DRTS
26%
Poorly correlated
+1.36%
RNAC - DRTS
25%
Poorly correlated
-0.97%
SAGE - DRTS
25%
Poorly correlated
+0.46%
ENLV - DRTS
23%
Poorly correlated
-1.75%
More